+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Breast Pathology Fellowship

Memorial Sloan Kettering Cancer Center

The Department of Pathology at Memorial Sloan Kettering Cancer Center offers one-year Breast Pathology Fellowship positions. All fellows should have completed residency training in anatomic pathology and be certified (or eligible for certification) by the American Board of Pathology.

The fellowship focuses on the characterization of mammary neoplasms and non-neoplastic diseases and emphasizes a multidisciplinary approach to patient management. Clinicopathologic and translational research is also an integral part of the training. The breast pathology fellows work closely with a cadre of breast pathology experts. The case material at MSK is especially complex and challenging and consists of both in-house specimens and submitted consultations. The breast pathology fellows actively participate in all clinical activities and present cases at the weekly multidisciplinary conference. The fellows are based at the state-of-the-art Evelyn H. Lauder Breast Center, and benefit from close interaction with a team of outstanding clinicians who specialize in the treatment of breast cancer patients. Selective rotations in the departments of surgery, radiology and radiation oncology enhance the understanding of the clinical aspects of breast diseases, and their implications for the practicing pathologist.

How to Apply

Apply Online

Once applicants have submitted their applications, they will need to send the following documents in order to be considered for a fellowship position:

Three letters of recommendation from an institution in which the applicant has trained. Letters should be addressed to Hannah Wen the program director. Please request letter writers add the following line after the heading (RE: Candidates Name, Program & Year Applying to)
CV
Copy of a medical school diploma and translation, if necessary.
International medical school graduates must submit a copy of their Educational Commission for Foreign Medical Graduates (ECFMG) certificate that is marked “valid indefinitely”

Additional Information

Goals and Objectives

Gain experience in the diagnosis of neoplastic diseases of the breast and their mimics.
Gain experience in the diagnosis of precursors of mammary neoplasia.
Gain experience in the diagnosis of non-neoplastic lesions of the breast and their mimics.
Develop an understanding of special techniques for pathologic characterization of diseases of the breast.
Develop an understanding of the clinical features of breast diseases, including diagnostic evaluation of patients, treatment algorithms, tumor staging parameters and prognostic indices.
Develop an appreciation of the multidisciplinary team approach for the treatment of patients with breast disease.
Enhance teaching skills through interaction with pathology, surgery and radiology fellows, students, and clinicians.
Develop appreciation for research methodology and utilize analytical techniques to complete research projects.

Responsibilities

The breast pathology fellows will review slides and prepare reports for selected in-house and submitted consultation cases, with increasing autonomy as the fellowship progresses. Responsibilities also include supervision of trainees, pathologist assistants and rotating visitors and participation in intradepartmental teaching conferences and journal club presentations. The fellows will present cases at the weekly multidisciplinary breast conference, and attend the intradepartmental breast pathology consensus conference and research meetings. The fellows will also participate in activities such as tissue procurement and review of archival pathology cases.

The breast pathology fellows will engage in both independent and collaborative research, select a limited number of primary research projects and pursue them under the guidance of the attending faculty. The fellows will prepare research proposals, participate in and coordinate the completion of projects, compile and analyze the data from these studies, prepare abstracts for submission to scientific meetings, and compile manuscripts for submission to peer-reviewed scientific journals.

AI Based Application Success Predictor

1. Direct relevance to cancer research and patient care (highest predictor)

The strongest predictor is clear alignment with MSK’s core mission in cancer research, treatment, and education. Competitive projects generally focus on areas such as:

Cancer biology and genetics
Tumor immunology and immunotherapy
Metastasis
Precision oncology
Cancer genomics
Drug resistance
Early detection and biomarkers
Clinical and translational oncology
Cancer surgery and radiation oncology
Cancer care delivery and symptom science

Projects with a clear connection to understanding, preventing, diagnosing, or treating cancer are the strongest fit.

2. Scientific excellence and high-impact potential (very high predictor)

MSK’s research environment is highly competitive. Strong proposals typically demonstrate:

An important scientific question
Strong biological or clinical significance
Potential to advance the field
A convincing scientific rationale
Clear and meaningful expected outcomes

Institutional developmental funding has been used to support emerging research areas and projects capable of strengthening broader cancer research programs.

3. Innovation and high-risk/high-reward potential (very high predictor)

Innovative science is a major feature of MSK’s internal and donor-supported research ecosystem. Strong applications often involve:

Novel biological concepts
New therapeutic strategies
Emerging technologies
Innovative computational approaches
Unconventional research directions

For example, MSK-associated discovery funding has supported compelling projects beyond an investigator’s existing funded research and collaborative high-risk/high-reward “grand challenge” projects.

4. Strong translational potential (very high predictor)

MSK places exceptional emphasis on moving scientific discoveries toward patient benefit.

Competitive projects often demonstrate a path toward:

New cancer therapies
Biomarker development
Improved patient selection
Clinical trials
Understanding therapeutic resistance
Better cancer outcomes

MSK’s K12 clinical oncology program explicitly focuses on training the next generation of translational cancer physicians, while its research programs integrate laboratory and clinical investigation.

5. Strong preliminary data and feasibility (high predictor)

Competitive research applications generally require enough evidence to show that the proposed work is achievable.

Strong proposals usually include:

Convincing preliminary observations
Appropriate models or datasets
Access to required technologies
Realistic milestones
Rigorous experimental design
A credible timeline

For pilot and developmental projects, preliminary data are especially valuable when they demonstrate that a novel idea can grow into a larger externally funded research program.

6. Outstanding investigator potential and research track record (high predictor)

Investigator quality is particularly important across MSK fellowships, career-development awards, and internal research programs.

Competitive applicants generally demonstrate:

Strong scientific productivity
Relevant publications
Technical expertise
Increasing independence
A coherent research trajectory
Potential for major future contributions

Some MSK-supported training mechanisms explicitly target researchers who show exceptional potential to make significant contributions to their fields.

7. Strong mentorship and research environment (high predictor)

For students, postdoctoral researchers, and early-career investigators, mentorship is a major success factor.

The strongest applications typically provide access to:

Experienced cancer investigators
Specialized laboratories
Clinical populations
Core facilities
Advanced technologies
Multidisciplinary collaborators

MSK maintains more than 200 research laboratories and provides institutional support for researchers seeking fellowships and external grants.

8. Multidisciplinary and cross-laboratory collaboration (high predictor)

Complex cancer problems often require collaboration among:

Basic scientists
Medical oncologists
Surgeons
Pathologists
Computational biologists
Imaging scientists
Immunologists
Biostatisticians

MSK’s institutional funding history specifically includes support for cross-disciplinary pilot projects, while donor-supported programs have funded collaborative high-risk/high-reward research involving multiple laboratories.

9. Potential to generate major external funding (high predictor)

A strategically strong MSK pilot project should create a pathway toward:

National Institutes of Health funding
National Cancer Institute grants
Foundation funding
Large collaborative awards
Clinical trial support

MSK’s Grants and Contracts infrastructure specifically assists researchers with proposal development, funding identification, and competitive external grant submission.

10. Strong career-development trajectory (program-specific but important)

For fellowships and training awards, the strongest candidate is not simply the person with the best project. Reviewers are also likely to value:

Clear career objectives
Commitment to cancer research
Appropriate training needs
Acquisition of new expertise
Potential for scientific independence
Future leadership

MSK’s fellowship and training programs are explicitly designed to prepare researchers and physicians for leadership roles in cancer research and care.

Specialties

Cancer

Oncology

Gynecology

Pathology

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: Memorial Sloan Kettering Cancer Center

Sponsor Type: Corporate/Non-Profit

Address: 1275 York Avenue New York, NY 10065

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity